Trials / Completed
CompletedNCT02914119
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals - a Cross-sectional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30,430 (actual)
- Sponsor
- Jakob Louis Thomsen · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Aim: To explore * the frequency of use of objective neuromuscular monitoring for assessment of depth of neuromuscular blockade in general anaesthesia * the incidence of residual neuromuscular blockade, and * the timing of reversal of the neuromuscular blockade at the end of anaesthesia. We will collect data from 7 Danish anaesthesia departments, using data from the Anaesthesia Information Management System (AIMS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rocuronium | |
| DRUG | Succinylcholine | |
| DRUG | Cisatracurium | |
| DRUG | Mivacurium | |
| DEVICE | Objective neuromuscular monitoring (acceleromyography) | |
| DRUG | Sugammadex | |
| DRUG | Neostigmine |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-09-26
- Last updated
- 2019-09-12
- Results posted
- 2019-09-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02914119. Inclusion in this directory is not an endorsement.